Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ameet Sarpatwari

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
JAMA Internal Medicine|November 30, 2020
Corrections to Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic SubstitutionsAmeet Sarpatwari
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 4, 2024
<b>Public Returns on Public Investment:</b> Moderna's Violation of the Social ContractAmeet Sarpatwari
JAMA|February 20, 2019
Mitigating Health Risks of Prescription Drugs: Lessons From FDA Oversight of Opioid ProductsAmeet Sarpatwari, Gregory Curfman
JAMA|July 2, 2016
Navigating the Dermatological Drug Cost CurveAmeet Sarpatwari, Aaron S Kesselheim
JAMA|May 18, 2026
The 340B Drug Pricing Program at a CrossroadsRyan P Knox, Ameet Sarpatwari
The New England Journal of Medicine|October 19, 2017
Recalibrating Privacy Protections to Promote Patient EngagementAmeet Sarpatwari, Niteesh K Choudhry
Pharmacoepidemiology and Drug Safety|June 10, 2016
Balancing benefits and harms: privacy protection policiesAmeet Sarpatwari, Joshua J Gagne
The New England Journal of Medicine|July 11, 2019
Reforming the Orphan Drug Act for the 21st CenturyAmeet Sarpatwari, Aaron S Kesselheim
JAMA Internal Medicine|January 23, 2019
Tepid Steps on Drug PricingAmeet Sarpatwari, Aaron S Kesselheim
Health Affairs Scholar|August 6, 2025
Legal challenges to the 340B drug pricing program: administration, regulation, and reformRyan P Knox, Ameet Sarpatwari
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
JAMA Internal Medicine|November 30, 2020
Corrections to Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic SubstitutionsAmeet Sarpatwari
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 4, 2024
<b>Public Returns on Public Investment:</b> Moderna's Violation of the Social ContractAmeet Sarpatwari
JAMA|February 20, 2019
Mitigating Health Risks of Prescription Drugs: Lessons From FDA Oversight of Opioid ProductsAmeet Sarpatwari, Gregory Curfman
JAMA|July 2, 2016
Navigating the Dermatological Drug Cost CurveAmeet Sarpatwari, Aaron S Kesselheim
JAMA|May 18, 2026
The 340B Drug Pricing Program at a CrossroadsRyan P Knox, Ameet Sarpatwari
The New England Journal of Medicine|October 19, 2017
Recalibrating Privacy Protections to Promote Patient EngagementAmeet Sarpatwari, Niteesh K Choudhry
Pharmacoepidemiology and Drug Safety|June 10, 2016
Balancing benefits and harms: privacy protection policiesAmeet Sarpatwari, Joshua J Gagne
The New England Journal of Medicine|July 11, 2019
Reforming the Orphan Drug Act for the 21st CenturyAmeet Sarpatwari, Aaron S Kesselheim
JAMA Internal Medicine|January 23, 2019
Tepid Steps on Drug PricingAmeet Sarpatwari, Aaron S Kesselheim
Health Affairs Scholar|August 6, 2025
Legal challenges to the 340B drug pricing program: administration, regulation, and reformRyan P Knox, Ameet Sarpatwari
Pageof 16